Today is the 2-year anniversary of my last dose of IFN. My post last year, link below, covers it well and I got the courage to read it today. I know that post has helped at least someone reduce the risk of my fate.
healthunlocked.com/mpnvoice...
In particular context of Sjogren’s and a year to learn from here and elsewhere, I’ve concluded my experience was one-of-a-kind to date. This is good for other IFN users. I’m not aware of any published case histories or member reports here of a single IFN dose instantly causing permanent personal mayhem via Sjo. For others there seems to be a graduated warning over weeks or months. Plenty of time to get any worries checked. But please do get them checked, whether it’s emergent with IFN or pre-existing the IFN.
One notable item I had forgotten is how high the Sjo risk is with IFN in the “ANNEX I” of the Bes Euro label “SUMMARY OF PRODUCT CHARACTERISTICS”
I wrote, “In the Euro label Sjo is the only (non-thyroid) A-I (autoimmune) listed as “common” (1-10% pts) on page 9 (34 and 46) here”
It follows that, while the severity is not reported, the "common" cases here were not like my experience since it was approved for marketing. Sjo is a unique autoimmune in this "common" class, even closely related Lupus is not a listed Bes risk in this reference. My impression from anecdotal posts here is the Sjo incident range in this report is plausible.
ema.europa.eu/en/documents/...
This report does not specify the gender of the Sjo pts. But so far all the related case reports I found and member experience I recall here have been women, which follows the 90% of Sjo pts that are women. The 10% that are men on average get a more severe disease expression (on average being the important qualifier) so as the lone representative male with IFN related Sjo my extreme experience may fit well. I have zero family history of autoimmune disease. But either gender can and do get strong presentations.
In sum, Sjogren's risk is significant with IFN, and suggests careful attention, but my crash and burn remains unique to date.
---
I continue to suspect the botched flu vax I got is tied to this outcome as I've posted. Disasters usually require a sequence of unlucky and unlikely events- this fits in my opinion. My husband discussed it today, he had told me to wait on the flu vax, but my GP said one week spacing was fine. I now know it’s not.
You should discuss with Dr my two suggestions (my opinion) for safest vax strategy:
1- As I’ve posted before: Do not get vaccines one week apart. Same day or preferably two weeks+ is safer. This is common knowledge among some, but not enough, practitioners. I got them at the same pharmacy and they did not screen for this. With three Fall vaxes these days it’s highly and newly relevant.
2- A new advice from an old memory- Be sure to fully expose your shoulder to the care giver. It’s the caregiver’s fault if they don’t insist on this but it’s the pt’s problem. My flu vax was misplaced (one of the steps in that sequence of events).
--
On Sjo treatments, there are now 5 promising therapies in phase 3, up from zero recently. I’ve contacted all 4 of the distinct trials near me. But the MPN and/or the Rux exclude me. I would switch to HU if it could get me these treatments. It would be worth risking a rise in VAF and the extra sides I had. There are possibly curative cell trials that I would qualify but they considered and passed on the Sjo indication. “It’s not serious enough”, a still too common perception. So I await approval in coming years and hope to hold up in the meantime.
If you have or know someone with Lupus, the close Sjo relative, there are numerous early cell trials ongoing, one with breakthrough status. This is all just starting the past year. It could be worth inquiry, these show potential for a durable remission or even cure. I think Sjo will get a cell trial at some point. These are distant relatives to the new CAR-T therapies in study for CALR.